Search Results - "BURAK, Kelly W"

Refine Results
  1. 1

    The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver by Shah, Hemant, MD MScCH(HPTE), Feld, Jordan J., MD MPH, Bilodeau, Marc, MD, Burak, Kelly W., MD MSc, Cooper, Curtis, MD, Klein, Marina, MD MSc, Ramji, Alnoor, MD, Smyth, Dan, MD

    “…Chronic hepatitis C virus (HCV) is a highly burdensome public health problem in Canada, causing more years of life lost than any other infectious disease in…”
    Get full text
    Journal Article
  2. 2

    An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver by Myers, Robert P, Shah, Hemant, Burak, Kelly W, Cooper, Curtis, Feld, Jordan J

    “…Chronic hepatitis C remains a significant medical and economic burden in Canada, affecting nearly 1% of the population. Since the last Canadian consensus…”
    Get full text
    Journal Article
  3. 3

    Association between Low Testosterone Levels and Sarcopenia in Cirrhosis: A Cross-sectional Study by Moctezuma-Velázquez, Carlos, Low, Gavin, Mourtzakis, Marina, Ma, Mang, Burak, Kelly W, Tandon, Puneeta, Montano-Loza, Aldo J

    Published in Annals of hepatology (01-07-2018)
    “…AbstractIntroduction and aim. Sarcopenia is an independent predictor of mortality in cirrhosis. Hypogonadism is common in cirrhosis and has been associated…”
    Get full text
    Journal Article
  4. 4

    Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: A population‐based study by Myers, Robert P., Shaheen, Abdel Aziz M., Fong, Andrew, Burak, Kelly W., Wan, Alex, Swain, Mark G., Hilsden, Robert J., Sutherland, Lloyd, Quan, Hude

    Published in Hepatology (Baltimore, Md.) (01-12-2009)
    “…The recent epidemiology and outcomes of primary biliary cirrhosis (PBC) in North America are incompletely described, partly due to difficulties in case…”
    Get full text
    Journal Article
  5. 5

    Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list by Myers, Robert P, Shaheen, Abdel Aziz M, Faris, Peter, Aspinall, Alexander I, Burak, Kelly W

    Published in PloS one (18-01-2013)
    “…Allocation of donor livers for transplantation in most regions is based on the Model for End-Stage Liver Disease (MELD) or MELD-sodium (MELDNa). Our objective…”
    Get full text
    Journal Article
  6. 6

    Impact of Hepatitis B Virus Genetic Variation, Integration, and Lymphotropism in Antiviral Treatment and Oncogenesis by Lau, Keith C K, Burak, Kelly W, Coffin, Carla S

    Published in Microorganisms (Basel) (24-09-2020)
    “…Chronic Hepatitis B Virus (HBV) infection poses a significant global health burden. Although, effective treatment and vaccinations against HBV are available,…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list by Myers, Robert P., Tandon, Puneeta, Ney, Michael, Meeberg, Glenda, Faris, Peter, Shaheen, Abdel Aziz M., Aspinall, Alexander I., Burak, Kelly W.

    Published in Liver international (01-09-2014)
    “…Background Modifications to the Model for End‐Stage Liver Disease (MELD) have been proposed to improve prioritization of liver transplant (LT) candidates…”
    Get full text
    Journal Article
  10. 10

    An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithm by Burak, Kelly W, Kneteman, Norman M

    Published in Canadian journal of gastroenterology (01-11-2010)
    “…Hepatocellular carcinoma (HCC) is one of only a few malignancies with an increasing incidence in North America. Because the vast majority of HCCs occur in the…”
    Get full text
    Journal Article
  11. 11

    Prognosis in the early stages of hepatocellular carcinoma: Predicting outcomes and properly selecting patients for curative options by Burak, Kelly W

    Published in Canadian journal of gastroenterology (01-09-2011)
    “…Selection of patients for curative treatment options for HCC depends on tumour bulk (size, number or volume) and liver function (as measured by Child-Pugh…”
    Get full text
    Journal Article
  12. 12

    Sofosbuvir-Based Therapy in the Pre-Liver Transplant Setting: The Canadian National Experience by Al-Judaibi, Bandar, Thomas, Benson, Wong, Philip, Benmassaoud, Amine, Chen, Jo-Hua, Dokus, M. Katherine, Hussaini, Trana, Bilodeau, Marc, Burak, Kelly W, Marotta, Paul, Yoshida, Eric. M

    Published in Annals of hepatology (01-05-2018)
    “…AbstractIntroduction and aim. Sofosbuvir (SOF)-based regimen has been shown to have high efficacy even in patients with decompensated cirrhosis. Treated…”
    Get full text
    Journal Article
  13. 13

    Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers by O’Neil, Conar R, Congly, Stephen E, Rose, M. Sarah, Lee, Samuel S, Borman, Meredith A, Charlton, Carmen L, Osiowy, Carla, Swain, Mark G, Burak, Kelly W, Coffin, Carla S

    Published in Annals of hepatology (01-03-2018)
    “…AbstractIntroduction. Quantitative hepatitis B surface antigen (qHBsAg) combined with HBV DNA may be useful for predicting chronic hepatitis B (CHB) activity…”
    Get full text
    Journal Article
  14. 14

    Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada by Hilsden, Robert J., Kneteman, Norman M., Swain, Mark G., Fick, Gordon H., Myers, Robert P., Meeberg, Glenda A., Burak, Kelly W., Bain, Vincent G.

    “…Background. Since 2002, the Model of End-Stage Liver Disease (MELD) has been used for allocation of liver transplants (LT) in the USA. In Canada, livers were…”
    Get full text
    Journal Article
  15. 15

    Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience by Faisal, Nabiha, MD, FCPS, Yoshida, Eric M, Bilodeau, Marc, Wong, Philip, Ma, Mang, Burak, Kelly W, Al-Judaibi, Bandar, Renner, Eberhard L, Lilly, Leslie B

    Published in Annals of hepatology (01-09-2014)
    “…AbstractIntroduction. Hepatitis C (HCV) continues to be the leading indication for liver transplantation (LT). Sustained virological response (SVR) rates to…”
    Get full text
    Journal Article
  16. 16

    Spontaneous Regression of Hepatocellular Carcinoma and Review of Reports in the Published English Literature by Burak, Kelly W., Coffin, Carla, Taylor, Nick, Chohan, Moaz B. Y., Bathe, Oliver F.

    Published in Case reports in medicine (01-01-2019)
    “…Background. Spontaneous regression of hepatocellular carcinoma (HCC) is a rare event, although it has been described by numerous groups. The long-term fate of…”
    Get full text
    Journal Article
  17. 17

    Frailty is associated with increased risk of cirrhosis disease progression and death by Wang, Sarah, Whitlock, Reid, Xu, Chelsea, Taneja, Sunil, Singh, Surender, Abraldes, Juan G., Burak, Kelly W., Bailey, Robert J., Lai, Jennifer C., Tandon, Puneeta

    Published in Hepatology (Baltimore, Md.) (01-03-2022)
    “…Background and Aims The Liver Frailty Index (LFI) is a well‐studied tool that evaluates frailty in patients with cirrhosis. Consisting of grip strength, chair…”
    Get full text
    Journal Article
  18. 18

    A Mixed Methods Study on the Effect of Flipping the Undergraduate Medical Classroom by Burak, Kelly, Raman, Maitreyi, Paget, Michael, Busche, Kevin, Coderre, Sylvain, McLaughlin, Kevin

    Published in Education sciences (01-12-2017)
    “…The flipped classroom model is increasingly being adopted in healthcare education, despite the fact that recent systematic reviews in the nursing and medical…”
    Get full text
    Journal Article
  19. 19
  20. 20